Phosphodiesterase 4 Inhibition in the Treatment of Psoriasis, Psoriatic Arthritis and Other Chronic Inflammatory Diseases

Agents which increase intracellular cyclic adenosine monophosphate (cAMP) may have an antagonistic effect on pro-inflammatory molecule production so that inhibitors of the cAMP degrading phosphodiesterases have been identified as promising drugs in chronic inflammatory disorders. Although many such...

Descripción completa

Detalles Bibliográficos
Autores principales: Wittmann, Miriam, Helliwell, Philip S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3680635/
https://www.ncbi.nlm.nih.gov/pubmed/23888251
http://dx.doi.org/10.1007/s13555-013-0023-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3680635/
https://www.ncbi.nlm.nih.gov/pubmed/23888251
http://dx.doi.org/10.1007/s13555-013-0023-0

Ejemplares similares